Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages (Q39716951)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 April 2010

Language	Label	Description	Also known as
English	Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages	scientific article published on 8 April 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Alexandra Miranville

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Andreas W Herling

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Gabriele Biemer-Daub

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Marc D Voss

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

8 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

2247-2254

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

21 January 2018

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

21 January 2018

Inflammatory mechanisms in the regulation of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

21 January 2018

Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

21 January 2018

Obesity and the role of adipose tissue in inflammation and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

A central role for JNK in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

The chemokine system in diverse forms of macrophage activation and polarization

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Monocyte and macrophage heterogeneity

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Macrophage activation and polarization

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Alternative versus classical activation of macrophages.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Alternative activation of macrophages

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Macrophage infiltration into adipose tissue: initiation, propagation and remodeling.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Macrophage-secreted factors induce adipocyte inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Role of macrophage tissue infiltration in metabolic diseases.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Effects of obesity surgery on the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Metabolic syndrome: yet another co-morbidity gastric bypass helps cure.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Rimonabant in rats with a metabolic syndrome: good news after the depression.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

The CB1 endocannabinoid system modulates adipocyte insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

The endocannabinoid system in obesity and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.81

31 March 2020

Identifiers

10.1038/OBY.2010.81

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39716951&oldid=2089113874"